This afternoon we watched CVS Health drop -3.3% to a price of $67.14 per share. The Large-Cap Pharmaceutical Retail company is now trading -12.81% below its average target price of $77.01. Analysts have set target prices ranging from $70.0 to $90.0 per share for CVS Health, and have given the stock an average rating of buy.
CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.5%. The stock's short ratio is 1.69. The company's insiders own 1.07% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 84.8%. In conclusion, we believe there is positive market sentiment regarding CVS Health.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-12-31 | Vanguard Group Inc | 9% | 117,366,367 | $7,880,564,318 |
| 2024-12-31 | Blackrock Inc. | 8% | 105,965,842 | $7,115,076,105 |
| 2024-12-31 | Dodge & Cox Inc | 6% | 70,105,899 | $4,707,260,353 |
| 2024-12-31 | Capital World Investors | 5% | 61,039,777 | $4,098,515,621 |
| 2024-12-31 | State Street Corporation | 5% | 56,952,959 | $3,824,106,240 |
| 2024-12-31 | FMR, LLC | 2% | 28,133,050 | $1,888,993,547 |
| 2024-12-31 | Geode Capital Management, LLC | 2% | 27,051,540 | $1,816,375,562 |
| 2024-12-31 | Capital International Investors | 2% | 26,666,401 | $1,790,515,405 |
| 2024-12-31 | Pzena Investment Management LLC | 2% | 19,610,579 | $1,316,752,261 |
| 2024-12-31 | NORGES BANK | 1% | 18,702,928 | $1,255,808,037 |
